// App-Quantinova.ai

INNV-26 : SERVICE RECONFIGURATION INTO AN URGENT ELECTIVE PATHWAY FOR THE MANAGEMENT OF GLIOBLASTOMA PATIENTS IMPROVES OUTCOMES, COSTS AND PATIENT EXPERIENCE AND ADJUNCT USE: A SINGLE CENTRE SIX YEAR REVIEW

Researchers

Presenter

  • Rosa Sun

Principal Investigators

  • Shivam Sharma

  • Colin Watts

  • Victoria Wykes

Medical Centers

  • University Hospitals Birmingham, Newcastle under Tyme, United Kingdom

  • Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom

  • University of Birmingham, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved